These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18622160)

  • 1. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.
    Rieder F; Fiocchi C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small bowel enteroscopy: territory conquered, future horizons.
    Semrad CE
    Curr Opin Gastroenterol; 2009 Mar; 25(2):110-5. PubMed ID: 19528878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease: immunologic concepts.
    Schreiber S
    Hepatogastroenterology; 2000; 47(31):15-28. PubMed ID: 10690582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
    Gordon JN; Di Sabatino A; Macdonald TT
    Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional and metabolic issues in inflammatory bowel disease.
    Cabré E; Gassull MA
    Curr Opin Clin Nutr Metab Care; 2003 Sep; 6(5):569-76. PubMed ID: 12913675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helminths and the modulation of mucosal inflammation.
    Elliott DE; Summers RW; Weinstock JV
    Curr Opin Gastroenterol; 2005 Jan; 21(1):51-8. PubMed ID: 15687885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.
    Rampton DS; Collins CE
    Aliment Pharmacol Ther; 1993 Aug; 7(4):357-67. PubMed ID: 8218751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond tumor necrosis factor: next-generation biologic therapy for inflammatory bowel disease.
    Podolsky DK
    Dig Dis; 2009; 27(3):366-9. PubMed ID: 19786766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach.
    Targan SR; Karp LC
    Curr Opin Gastroenterol; 2007 Jul; 23(4):390-4. PubMed ID: 17545774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X
    Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel diagnostic and prognostic modalities in inflammatory bowel disease.
    Zisman TL; Rubin DT
    Med Clin North Am; 2010 Jan; 94(1):155-78. PubMed ID: 19944803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.
    Uhlig HH; Powrie F
    Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-glial crosstalk in inflammatory bowel disease.
    Neunlist M; Van Landeghem L; Bourreille A; Savidge T
    J Intern Med; 2008 Jun; 263(6):577-83. PubMed ID: 18479256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.